This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history
- Farnaz Tabatabaian, Dennis K Ledford
- Journal of Asthma and Allergy, April 2018, Dove Medical Press
- DOI: 10.2147/jaa.s107982
